Research Topics
| B BrorssonSummaryAffiliation: The Swedish Council on Technology Assessment in Health Care Publications
| Collaborators |
Detail Information
Publications
CABG in chronic stable angina pectoris patients: indications and outcomes (SECOR/SBU). Swedish Societies for Cardiology, Thoracic Radiology and Thoracic surgery/Swedish Council for Technology Assessment in Health CareB Brorsson
Swedish Council on Technology Assessment in Health Care Statens beredning för medicinsk utvärdering, Stockholm
Eur J Cardiothorac Surg 12:746-52. 1997..This article presents the indications and outcomes in the largest intervention group, chronic stable angina pectoris treated by first time CABG...
Quality of life of chronic stable angina patients 4 years after coronary angioplasty or coronary artery bypass surgeryB Brorsson
The Swedish Council on Technology Assessment in Health Care, Stockholm, Sweden
J Intern Med 249:47-57. 2001..To evaluate the quality of life experienced by chronic stable angina patients with one- or two-vessel coronary artery disease treated with percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass graft (CABG)...
Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal populationB Brorsson
The Swedish Council on Technology Assessment in Health Care, Stockholm, Sweden
Heart 87:140-5. 2002..To assess the impact of coronary revascularisation on the health related quality of life (HRQOL) of patients with chronic stable angina compared with data from "community" norms four years following revascularisation...
Quality of life in patients with chronic type B aortic dissectionA Winnerkvist
Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital, Stockholm, Sweden
Eur J Vasc Endovasc Surg 32:34-7. 2006..To study functioning and well-being among patients with conservatively treated acute type B aortic dissection...
A prospective study of the use of chemotherapy in Sweden and assessment of the use in relation to scientific evidenceP Ragnhammar
Radiumhemmet, Stockholm, Sweden
Acta Oncol 40:391-411. 2001..by not discontinuing treatment despite the absence of clinical benefits. Likewise, one cannot exclude the possibility of underutilisation, e.g. by patients declining treatment because they were not informed about the potential benefits...
